How can spatial proteomics be implemented in clinical research settings? - with Tad George

Tad George, PhD, SVP of R&D Biology at RareCyte, shares proven strategies for deploying high-plex spatial proteomics in clinical and translational studies. This DDN Industry Shaping Science interview covers real-world hurdles, workflows, and tools for large-cohort trials and biomarker validation. Key topics: • Top hurdles in clinical/translational implementation and practical solutions • Essential advice for teams adopting spatial proteomics • Why multiplex immunofluorescence drives translational success • Orion's 20-channel single-round imaging: enabling the plex, throughput, and data quality for clinical-scale studies • Key technology features for clinical success: reproducible performance, flexible panels, and high-throughput scanning for trial demands 👉 Learn more: rarecyte.com/orion.html 👉 RareCyte: rarecyte.com